The akr1b7 gene encodes an aldose reductase-like protein that is responsible for detoxifying isocaproaldehyde generated by the conversion of cholesterol to pregnenolone. The regulation of gene expression by human chorionic gonadotropin (hCG) was first investigated in the MA-10 Leydig tumor cell line. The akr1b7 gene was constitutively expressed and accumulation of its mRNA was increased in a dose-and time-dependent manner by treatment with hCG. akr1b7 mRNA accumulation was sharply increased in the presence of 0·25 nM hCG and it reached a fivefold increase within 2 h. AKR1B7 protein accumulation was delayed compared with that of the corresponding mRNA. In agreement, hCG significantly increased the levels of mRNA and protein of akr1b7 in primary cultures of adult mouse Leydig cells, thus suggesting that LH potentially regulates akr1b7 gene expression in vivo. Expression of akr1b7 was developmentally regulated in the testis. Unexpectedly, levels of akr1b7 mRNA increased from embryonic day 15 to the day of birth and declined until adulthood while AKR1B7 protein levels followed an inverse pattern, suggesting an important role for translational mechanisms.
Introduction
Cholesterol, the essential sterol found in vertebrates, is the substrate for the synthesis of steroid hormones such as mineralocorticoids, glucocorticoids and sex steroids. Steroid hormones, which act as endocrine messengers, are synthesized in the adrenals, gonads, placenta and brain. Steroidogenesis in adrenal and gonadal cells and its regulation by trophic hormones are well documented (Miller 1988 , Simpson & Waterman 1988 . The first and rate-limiting step in gonadal and adrenal steroidogenesis is the mobilization of cholesterol from cellular stores to the mitochondrial inner membrane mediated by at least two intracellular molecules: the steroidogenic acute regulatory protein (StAR) and the peripheral-type benzodiazepine receptor (Stocco & Clark 1997 , Papadopoulos 1998 . Steroidogenesis begins with the conversion of cholesterol into pregnenolone and isocaproaldehyde (4-methyl pentanal). The reaction is catalyzed by the cytochrome P450 side-chain cleavage (P450 scc) enzyme which resides in the inner mitochondrial membrane (Privalle et al. 1983) . After leaving the mitochondrion, pregnenolone is transferred to endoplasmic reticulum to give rise to several other steroids via different pathways. This process is highly regulated by trophic hormones, such as adrenocorticotropin (ACTH) and gonadotropins, acting via intracellular cAMP and subsequent activation of the protein kinase A (PKA) signaling pathway (Hanukoglu et al. 1990 ).
Whereas few tissues are able to synthesize steroid hormones, many tissues of the body can metabolize steroids. The aldo-keto reductases (AKRs) are an enzyme superfamily of NAD(P)H oxidoreductases that catalyze the reduction of a wide variety of substrates including aldoses, aliphatic and aromatic aldehydes, ketones, prostaglandins and xenobiotics ( Jez et al. 1997) . The AKR superfamily contains steroid transforming enzymes that play pivotal roles in the inactivation and action of sex steroids. Cluster analysis showed that the first family (AKR1) of the superfamily includes aldehyde reductases (AKR1A), aldose reductases (AKR1B) and the hydroxysteroid dehydrogenases (AKR1C). While the expression and regulation of steroidogenic genes have been studied extensively, those involved in steroid catabolism have not been well characterized. AKR1B7, an aldose reductase-like protein, represents the major secretory component of the mouse vas deferens (Taragnat et al. 1988 ). However, this expression profile is restricted to the mouse species (Taragnat et al. 1990) . In vivo and in vitro studies have demonstrated that androgens are the major regulator of akr1b7 gene expression in the vas deferens , Fabre et al. 1994 , Darne et al. 1997 . AKR1B7 was shown to be highly expressed in adrenals from various rodents, under the control of pituitary ACTH (Aigueperse et al. 1999 ) and where it acts as a major reductase for isocaproaldehyde, a harmful aldehyde generated by steroidogenesis (Lefrancois- . Lately, using proteome analysis, Brockstedt et al. (2000) have identified AKR1B7 as a protein induced by luteinizing hormone (LH) in the murine ovary. All steroidogenic cells catalyze the transformation of cholesterol to pregnenolone and produce isocaproaldehyde. It might be postulated that AKR1B7 is expressed and plays the same detoxifying role in all steroidogenic cells. The objectives of the current study were to determine if Leydig cells express akr1b7 at mRNA and protein levels under the control of LH/human chorionic gonadotropin (hCG) and to examine the developmental pattern of akr1b7 gene expression in testis.
Materials and methods

Animals
Adult mice (Swiss strain CD-1; Charles River, L'arbresle, France) were housed under standard animal housing conditions in accordance with the NIH guide for the care and use of laboratory animals. Female animals were placed in individual cages with males, and the morning on which a vaginal plug was found was designated day 0 (E0) of pregnancy.
Purification of Leydig cells and cell culture
This purification technique was first described by Lefevre et al. (1983) . Briefly, testes from 30-day-old male mice were decapsulated and incubated for 20 min at 33 C in Dulbecco's modified Eagle's medium (DMEM)/Ham's F12 (1:1), transferrin (5 µg/ml), insulin (4 µg/ml) and vitamin E (0·2 µg/ ml) medium containing collagenase (0·8 mg/ml) (Life Technologies, Invitrogen, Cergy-Pontoise, France). Crude extracts were collected by centrifugation for 10 min at 200 g and the pellet was resuspended in fresh medium. Following two successive sedimentations, the supernatant containing Leydig cells was centrifuged and the pellet was resuspended in fresh medium at a final concentration of 10 7 cells/ml. Five milliliters of the suspension was layered on top of a discontinuous Percoll gradient (four layers from 21 to 60%) prepared from a stock solution (90% Percoll:10% Ham's F10 (10 ), 20 mM Hepes, 140 mM NaHCO 3 , pH 7·4) diluted with DMEM/Ham's F12. After centrifugation for 30 min at 2000 g at 4 C, purified Leydig cells were collected at the 60-34% layer interface, diluted in fresh medium and washed twice. Cells were seeded in fetal calf serum-pretreated six-well plates (1·8 10 6 cells/ well) in DMEM/Ham's F12 (1:1), transferrin (5 µg/ml), insulin (4 µg/ml) and vitamin E (0·2 µg/ ml) medium. The medium was changed every 24 h.
Murine MA-10 Leydig tumor cells (Ascoli 1981) were grown in Waymouth's medium (Life Technologies) supplemented with 15% horse serum, 2 mM -glutamine, penicillin (100 U/ml) and streptomycin (100 µg/ml) (Life Technologies). Prior to hormone treatment, cells were cultured for 24 h in DMEM/Ham's F12 (1:1) medium in the absence of serum. In the experiments involving inhibitors, they were added 1 h before hormones or activators.
Northern blot analysis
Total RNA was extracted from MA-10 cells, Leydig cells or testes with TRIzol (Life Technologies) according to the manufacturer's instructions. Total RNA (30 µg) was separated in a 1% (w/v) agarose gel and 2·2 M formaldehyde gel and transferred onto Hybond N+ nylon membranes (Amersham Pharmacia Biotech, Orsay, France). The 3 UTR akr1b7 cDNA fragment (+975/+1176 with respect to the numbering of the akr1b7/mvdp sequence NM_009731; Genbank), and P450 scc, glyceraldehyde 3-phosphate dehydrogenase (gadph) and -actin cDNAs were labeled with the 32 P-dCTP NEBlot kit (New England Biolabs, Ozyme, Saint-Quentin en Yvelines, France). Prehybridization was carried out for 2 h at 65 C in 3 SSC, 0·2% PVP, 0·2% Ficoll, 5% PEG, 1% glycine, 1% SDS and 100 µg/ml sonicated salmon sperm DNA. Hybridization was performed overnight in the same solution in the presence of 10 6 c.p.m./ml labeled probes. After washing, blots were exposed to an imaging screen K (BioRad, Marnes-laCoquette, France) and visualized using a BioRad molecular imager FX phospho-imager. Hybridization signals were analyzed using the Quantity One quantification software (BioRad).
RT-PCR
Equal amounts of total RNA (2 µg) were reverse transcribed in the presence of 100 pmol random hexanucleotides using 200 U M-MLV reverse transcriptase (Promega, Charbonnieres, France) according to the manufacturer's instructions. First-strand cDNAs were amplified by PCR using, in combination, 100 pmol specific primers for akr1b7 (5 -TCACTCAGAGAACTCTCTGC-3 , 5 -ATCATGCACGGATCTCATCA-3 ) and gapdh (5 -CATCACCATCTTCCAGGA-3 , 5 -CACCA CCTTCTTGATG TC-3 ) in the presence of 5 U Taq polymerase (Goldstar; Eurogentec, Seraing, Belgium). Equal volumes of PCR products were collected after 15 amplification cycles and analyzed by agarose gel electrophoresis.
Western blot analysis
A fraction of cell sample was collected before RNA extraction and suspended in 0·25 M Tris-HCl, pH 7·5. Cells were lysed by sonication. Soluble proteins were recovered by centrifugation (15 min, 10 000 g, 4 C) and quantitated by the Bradford method (BioRad). Proteins were subjected to SDS-PAGE on 10% acrylamide gels and transferred onto nitrocellulose membranes (Amersham Pharmacia Biotech). Non-specific protein-binding sites were blocked by incubation for 1 h at room temperature in 50 mM Tris-HCl, pH 8, 150 mM NaCl and 0·1% (v:v) Tween 20 (TBS-T) containing 10% (w:v) non-fat dry milk. Incubation with the polyclonal anti-AKR1B7 L3 antibody (1:3000) (Val et al. 2002) was carried out overnight at 4 C. After washing in TBS-T, membranes were incubated for 1 h at room temperature with the peroxidaseconjugated anti-rabbit IgG (1:10 000) (P.A.R.I.S, Compiègne, France). Blots were washed and peroxidase activity detected by autoradiography with the ECL system (Amersham Pharmacia Biotech). Hybridization signals were quantified using the molecular analyst software (BioRad).
Immunolocalization of AKR1B7 in Leydig cell primary cultures
Cells seeded on coverslips were fixed in the culture well with 95% methanol and 5% acetic acid for 8 min, and permeabilized in the presence of phosphate-buffered saline (PBS) and 0·1% Triton for 4 min. Cells were incubated overnight at 4 C with the L3 antibody (1:150). After washing in PBS, non-specific protein-binding sites were blocked by incubation with PBS and 5% goat serum. Incubation with the FITC (fluorescin isothiocyanate) anti-rabbit IgG (1:150) was carried out for 1 h at room temperature. A negative control was included by replacing the primary antibody with PBS. Cells were washed in PBS and slides were observed under UV irradiation with a photonic microscope (Zeiss, Le Pecq, France).
Chemical localization of 3 -hydroxysteroid dehydrogenase (3 -HSD) activity
Cells grown on coverslips were incubated for 4 h in 0·1 M phosphate buffer containing 1·5 mM NAD + , 0·25 mM nitro blue tetrazolium, nicotinamide and 0·4 mM 3 -hydroxy-5 -androstan-17 -one, as described previously (Payne et al. 1980) .
Results hCG induces akr1b7 expression in MA-10 mouse Leydig tumor cells: involvement of the cAMP/PKA pathway
The biosynthesis of androgens is stimulated through the LH/hCG receptor, a G proteincoupled receptor, after coupling to cAMPdependent protein kinases. In order to determine whether LH/hCG can control akr1b7 expression in Leydig cells, Northern blot and Western blot analyses were performed in MA-10 cells stimulated with increasing doses of hCG for 6 h (Fig. 1A) . The pattern of hCG induction of akr1b7 was compared akr1b7 expression in Leydig cells · S BARON and others
Figure 1
Effects of hCG on P450Scc mRNA levels and akr1b7 mRNA and protein levels in MA-10 cells. MA-10 cells were incubated for 6 h with increasing concentrations of (A) hCG or (B) with 0·25 nM hCG for 2-48 h. Total cytoplasmic RNAs were isolated as described in Materials and methods, subjected to Northern blot analysis and hybridized sequentially with akr1b7, P450Scc and -actin cDNA probes. Total cytoplasmic proteins were isolated as described in Materials and methods, separated by SDS-PAGE migration and subjected to Western blot analysis. Immunodetection was performed with the L3 antibody (1/3000 e ). The blots presented are representative of three independent experiments.
with that of the cholesterol side-chain cleavage enzyme P450 scc, which is known to be regulated by the LH/hCG hormone and which produces isocaproaldehyde, the best substrate for AKR1B7 . In the absence of hCG, akr1b7 mRNA was expressed at low levels. As observed for P450 scc, hCG significantly increased akr1b7 mRNA levels at a concentration of 0·25 nM, and maximal induction was attained with 2·5 nM hCG. The action of hCG was time dependent and first detectable after 2 h of treatment (Fig. 1B) . Maximum induction with 0·25 nM hCG was about fivefold after 6 h and the mRNA levels returned to basal values after 24 h. The kinetics of the hCG regulation of P450 scc followed a similar pattern to that observed for akr1b7. P450 ssc mRNA levels showed a marked increase at 2 and 4 h and decreased up to 24 h (Fig. 1B) . These patterns were also observed for StAR and P450c17 (data not shown). On the basis of Western blot analysis, treatment of MA-10 cells with increasing concentrations of hCG markedly enhanced the level of AKR1B7 protein relative to that of untreated control cultures (Fig. 1A) . However, whereas the first increase in mRNA levels occurred 2 h after hCG addition, the significant enhancement in protein concentration was detected only at 6 h (Fig. 1B) .
In Leydig cells, expression of steroidogenic enzymes and the cholesterol transporter StAR in response to LH/hCG involves the cAMP signaling pathway. To ascertain whether hCG operates through PKA to induce akr1b7 gene expression, MA-10 cells were treated either with forskolin which potentiates cAMP synthesis or with H89, a PKA specific inhibitor. A 6-h induction with 10 5 M forskolin resulted in a 3·5-fold stimulation of akr1b7 mRNA accumulation (Fig. 2A) . Accordingly, the stimulating effect of hCG was reduced with 0·2 µM and completely abolished with 0·5 µM H89, further indicating that hCG-stimulated expression of akr1b7 was mediated by the cAMP/PKA pathway. To provide evidence on the transcriptional regulation of the akr1b7 gene in response to hCG, MA-10 cells were incubated in the presence or absence of the transcription inhibitor actinomycin D (Fig. 2B ). When treated with hCG alone, cells accumulated large amounts of akr1b7 mRNA. The presence of actinomycin D in the medium completely abolished this accumulation, thus indicating that the main control level of hCG on the akr1b7 gene expression takes place at the transcriptional level.
hCG induces akr1b7 expression in primary Leydig cells
To assess the physiological relevance of the effects observed with the murine Leydig tumor cells MA-10, hCG induction of akr1b7 expression was analyzed in enriched mouse primary Leydig cell cultures. The results summarized in Fig. 3A   Figure 2 Effects of H89 and forskolin on akr1b7 levels in MA-10 cells. MA-10 cells were incubated for 1 h in the presence or absence of increasing concentrations of (A) the PKA inhibitor H89 or (B) 1 µg/ml actinomycin D (Act-D) before treatment with or without 0·25 nM hCG or 10 µM forskolin (an adenylate cyclase activator) for 6 h. Total cytoplasmic RNAs were isolated as described in Materials and methods, subjected to Northern blot analysis and hybridized sequentially with akr1b7 and β-actin cDNA probes. The blots presented are representative of three independent experiments.
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represent the time-dependent increase in steadystate levels of akr1b7 in response to 0·25 nM hCG. akr1b7 transcripts were detected from 4 h of induction and the magnitude of the response was maximal at 8 h. The mRNA levels decreased slowly thereafter. Immunocytochemistry was performed directly on pubertal mouse primary cultured Leydig cells with immune rabbit serum directed against AKR1B7. The Leydig cells were distinguished from contaminating cells by their cytochemical staining for 3 -HSD staining. Leydig cells exhibited positive fluorescence strictly limited to the cytoplasm and it was strongly enhanced after 24 h of hCG treatment (Fig. 3B) . Specificity for AKR1B7 immunostaining was evident by the absence of reactivity when the primary antibody was omitted. Taken together, these results clearly demonstrated that akr1b7 expression is under LH/hCG control in primary Leydig cells.
The akr1b7 gene is developmentally expressed in testes
In the mouse, histologic differentiation of the fetal Leydig cells occurs at E12 and testosterone formation begins shortly after (E12·5) (O'Shaughnessy et al. 1998) . To determine the pattern of expression of the akr1b7 gene, RNA was extracted from testes isolated from mice at various embryonic and postnatal stages and analyzed by Northern blot (Fig. 4) and RT-PCR (data not shown). On E16·5, the earliest age tested, akr1b7 transcripts were very faintly detected. Thereafter, these levels increased sharply and reached a peak on day 6, before declining at day 10 and returning to basal levels at day 16 ( Fig. 4A and C) . The akr1b7 mRNA levels were higher in the early postnatal period than at adulthood. Western blot analysis revealed that the protein accumulation pattern was clearly different from that of mRNA. Even though detectable at E16·5, AKR1B7 levels strongly increased from day 3, reaching a maximum at day 20 ( Fig. 4B and C) and remained high during adulthood. Akr1b7 mRNA and protein levels increased during fetal and perinatal life, but only protein accumulation was retained after 10 days of age when mRNA levels were dramatically reduced. The very low mRNA accumulation at adulthood is specific to akr1b7 since it was not observed for steroidogenic enzymes such as P450 scc and cytochrome P450 17 -hydroxylase (P450c17) (data not shown).
Discussion
The restricted expression of the P450 scc gene to steroidogenic tissues determines whether a cell is capable of converting cholesterol to pregnenolone (Miller 1988) . The role of AKR1B7, which acts as a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol generated during steroidogenesis, suggests a similar pattern of expression. Studies from our own and other laboratories have demonstrated that AKR1B7 is expressed in adrenals and ovaries (Lau et al. 1995 , Aigueperse et al. 1999 , Brockstedt et al. 2000 . The bulk of steroid hormone synthesis in the testis is confined to the Leydig cells. This report describes, for the first time, the expression of the akr1b7 gene in both the MA-10 tumor cell line and primary cultures of mouse Leydig cells. Initial studies revealed the cell-type specificity of akr1b7 expression within the ovary and the adrenal gland. Immunohistochemical studies have shown that AKR1B7 was detected only in the cells of the zona fasciculata in adrenals (Aigueperse et al. 1999) . In the ovary, in situ hybridization localized akr1b7 mRNA to thecal and interstitial cells (Brockstedt et al. 2000) . This distribution in adrenals and gonads was expected, considering the function of the protein in detoxifying isocaproaldehyde. However, it has been reported that not all of the steroidogenically active cells showed akr1b7 expression since the products of the gene were undetectable in the zona glomerulosa and zona reticularis in adrenals (Aigueperse et al. 1999) and in the corpus luteum (Brockstedt et al. 2000) . Previous results have demonstrated that aldose reductase AKR1B1 has the ability to reduce isocaproaldehyde (Matsuura et al. 1996) . The expression of aldose reductase in adrenals (Inazu et al. 1994) and rat granulosa cells (Iwata et al. 1996) suggested a role in reducing isocaproaldehyde, especially in steroidogenic cells which were devoid of AKR1B7.
The endocrine regulation of Leydig cells occurred predominantly through the LH/hCG receptor after coupling to the adenylate cyclase signal transduction pathway. The present study shows that akr1b7 mRNA and protein levels were increased in response to hCG stimulation in a timeand dose-dependent manner in MA-10 mouse Leydig tumor cells. Accordingly, hCG significantly increased akr1b7 expression in a primary culture of adult mouse Leydig cells. The hCG-induced akr1b7 gene expression was abolished following treatment of MA-10 cells with the PKA inhibitor H89, indicating a critical role of the PKA signaling pathway in regulating akr1b7 expression in the Leydig cells. Moreover, forskolin, an activator of adenylate cyclase, mimicked the hCG-induced akr1b7 mRNA accumulation. This is in agreement with results showing that cAMP is an inducer of akr1b7 gene expression in specific steroidogenic cells within the adrenals and ovaries. When given acutely, LH increased testosterone synthesis within 30 min by enhancing the transport of cholesterol to the inner mitochondrial membrane and its association with P450 scc. In the steady state, LH akr1b7 expression in Leydig cells · S BARON and othersstimulated testosterone synthesis by increasing transcription of the P450 scc gene and other genes involved in the pathway (Miller 1988) . The transcripts of the akr1b7 gene were first detected 2 h after hCG treatment and their accumulation was sensitive to the transcription inhibitor actinomycin D, suggesting a relatively early transcriptional regulation. Interestingly, the results showed that expression of both akr1b7 and P450 scc genes, the products of which are involved in the first step in steroidogenesis, appeared temporally co-ordinated by LH/hCG in Leydig cells. Similar results have been reported in adrenals (Aigueperse et al. 2001) , suggesting that co-ordinated expression of both genes is physiologically important and providing evidence that they are linked to a common regulatory cascade. The transcription of steroid hydroxylase genes, including P450 scc, are controlled in the adrenals by ACTH via cAMP. However, each gene utilizes its own unique cAMP-responsive system (Waterman 1994) . Functional analyzes of the 5 -flanking regions have revealed that cAMP-dependent transcriptional regulation of bovine P450 scc gene was mediated by steroidogenic factor-1 (SF1) plus specific promoter factor-1 (Liu & Simpson 1997) . The orphan nuclear receptor SF1 is a key regulator of other different steroidogenic genes (Parker & Schimmer 1997) . SF1 presents a limited tissue distribution and recognizes a conserved regulatory region consensus site in the proximal promoter of a number of these genes (Morohashi 1999) . It was previously reported that the SF1 protein interacts specifically with a non-canonical regulatory element located in the downstream half site of an androgen response element within the promoter of akr1b7 (Aigueperse et al. 2001) . However, SF1 regulates the basal level of akr1b7 gene expression while SP1 and CCAAT/enhancer binding protein are required for cAMP responsiveness in murine adrenocortical cells (Aigueperse et al. 2001) . The molecular mechanisms involved in the regulation of akr1b7 expression in Leydig cells remain to be determined.
There was an increase in akr1b7 mRNA levels from E15 to the day of birth and a decline thereafter. In the mouse testis, P450 scc mRNA accumulation followed a similar pattern from E15 to day 5 (O'Shaughnessy et al. 1998) . This temporal coincidence suggested that expression of both genes was developmentally co-ordinated during fetal and perinatal life. Mice with destruction of the fetal hypophysis (Raynaud & Frilley 1947) or disruption of the common pituitary -subunit (Kendall et al. 1995) showed a normal male phenotype at birth, indicating that production of androgens by the fetal testis is pituitary independent. In hypogonadal mice, which lack gonadotropin-releasing hormone and thus gonadotropins, levels of mRNA encoding P450 scc and P450c17 were normal until birth (O'Shaughnessy et al. 1998 ). These observations suggested that either akr1b7 was constitutively expressed during fetal testicular development, or that factors other than LH induced its transcription. Since the placenta does not secrete gonadotropins in rodents (Tepper & Roberts 1984) , paracrine factors such as growth factors and cytokines might be involved as regulators of Leydig cell function (Lejeune et al. 1998) . The maximal levels of akr1b7 and P450 scc mRNAs, measured at day 1, coincide with a serum gonadotropin and testosterone surge which occurs during the first few hours after birth in rodents (Corbier et al. 1978) . The decrease observed in akr1b7 mRNA levels after day 3 was perhaps related to the prepubertal regression of Leydig cells (Gondos 1980) and an associated decline in testosterone production (Jean-Faucher et al. 1978) . Surprisingly, akr1b7 mRNA levels remained low in males aged 30 and 45 days despite the rise in plasma LH and the increased testicular responsiveness which occurred between 20 and 40 days (Jean-Faucher et al. 1983a,b) . AKR1B7 protein exhibited an inverse developmental pattern with levels increasing until adulthood, indicating that regulation of mRNA translation is an important aspect of the control of akr1b7 expression. The data suggested that an Figure 4 akr1b7 mRNA and protein accumulation during mouse development. (A) Total RNA from testes of animals killed at different developmental stages were subjected to Northern blot analysis and hybridized sequentially with akr1b7 and -actin cDNA probes. (B) Total cytoplasmic proteins were isolated as described in Materials and methods, and were separated by SDS-PAGE migration and subjected to Western blot analysis. Immunodetection was performed with the L3 antibody. The relative accumulation of akr1b7 mRNA and protein during development is shown in (C). These results are representative of two independent experiments. akr1b7 expression in Leydig cells · S BARON and othersincrease in translational efficiency, occurring during sexual maturation, allowed high AKR1B7 protein expression in the presence of decreasing mRNA levels. There was not always a correlation between the levels of mRNA and protein in steroidogenic enzyme expression processes. In the adrenals of rats which had received ACTH for 9 days, the levels of P450 ssc mRNA were unchanged whereas its protein concentration was significantly increased (Lehoux et al. 1998) . Interestingly, LH receptor mRNA level was lower in adult than in immature rat Leydig cells, whereas [
125 I]hCG binding was higher in the former (Shan & Hardy 1992) . Translation rates are modulated in response to growth factors, hormones and mitogens. Leydig cell function is also under paracrine control in vivo. The importance of such paracrine effects is supported by the differential akr1b7 expression control in adult primary culture cells and in the testis. It has also been shown that growth factors might increase gonadotropin-stimulated testosterone production (Lejeune et al. 1998) . Further experiments need to be carried out to identify the factors and mechanisms responsible for the changes observed in the translational efficiency of akr1b7 mRNA in the testis.
